title: Effects of hypercapnic hyperpnea on recovery from isoflurane or sevoflurane anesthesia in horses.
abstract: OBJECTIVE
  To test the hypothesis that hypercapnic hyperpnea produced using endotracheal insufflation with 5-10% CO(2) in oxygen could be used to shorten anesthetic recovery time in horses, and that recovery from sevoflurane would be faster than from isoflurane.
  
  
  METHODS
  Randomized crossover study design.
  
  
  METHODS
  Eight healthy adult horses.
  
  
  METHODS
  After 2 hours' administration of constant 1.2 times MAC isoflurane or sevoflurane, horses were disconnected from the anesthetic circuit and administered 0, 5, or 10% CO(2) in balance O(2) via endotracheal tube insufflation. End-tidal gas samples were collected to measure anesthetic washout kinetics, and arterial and venous blood samples were collected to measure respiratory gas partial pressures. Horses recovered in padded stalls without assistance, and each recovery was videotaped and evaluated by reviewers who were blinded to the anesthetic agent and insufflation treatment used.
  
  
  RESULTS
  Compared to isoflurane, sevoflurane caused greater hypoventilation and was associated with longer times until standing recovery. CO(2) insufflation significantly decreased anesthetic recovery time compared to insufflation with O(2) alone without significantly increasing PaCO(2) . Pharmacokinetic parameters during recovery from isoflurane with CO(2) insufflation were statistically indistinguishable from sevoflurane recovery without CO(2). Neither anesthetic agent nor insufflation treatment affected recovery quality from anesthesia.
  
  
  CONCLUSIONS
  Hypercapnic hyperpnea decreases time to standing without influencing anesthetic recovery quality. Although the lower blood gas solubility of sevoflurane should favor a shorter recovery time compared to isoflurane, this advantage is negated by the greater respiratory depression from sevoflurane in horses.
authors.affiliation: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA, USA. rjbrosnan@ucdavis.edu
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Brosnan
authors.forename: Eugene P
authors.initials: EP
authors.lastname: Steffey
authors.forename: André
authors.initials: A
authors.lastname: Escobar
mesh_terms: D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation / Q000009:adverse effects / Q000662:veterinary*; D018685:Anesthetics, Inhalation / Q000009:adverse effects; D000818:Animals; D002245:Carbon Dioxide / Q000627:therapeutic use*; D005260:Female; D006736:Horses / Q000502:physiology; D006935:Hypercapnia / Q000662:veterinary; D007040:Hypoventilation / Q000662:veterinary; D007442:Intubation, Intratracheal / Q000662:veterinary; D007530:Isoflurane / Q000009:adverse effects; D008297:Male; D008738:Methyl Ethers / Q000009:adverse effects; D056152:Respiratory Rate / Q000187:drug effects; D000077149:Sevoflurane
chemical_list: D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D002245:Carbon Dioxide; D000077149:Sevoflurane; D007530:Isoflurane